Trilogy Capital Inc. Acquires Shares of 3,800 Clorox Co (CLX)

Trilogy Capital Inc. purchased a new position in shares of Clorox Co (NYSE:CLX) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 3,800 shares of the company’s stock, valued at approximately $565,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Phocas Financial Corp. acquired a new position in shares of Clorox during the 2nd quarter worth about $167,000. Dupont Capital Management Corp acquired a new position in shares of Clorox during the 3rd quarter worth about $199,000. Smith Moore & CO. acquired a new position in shares of Clorox during the 3rd quarter worth about $204,000. Private Asset Management Inc. acquired a new position in Clorox in the 4th quarter valued at approximately $208,000. Finally, WFG Advisors LP raised its holdings in Clorox by 7.2% in the 2nd quarter. WFG Advisors LP now owns 1,571 shares of the company’s stock valued at $209,000 after acquiring an additional 106 shares in the last quarter. Institutional investors own 74.11% of the company’s stock.

Shares of Clorox Co (NYSE CLX) traded up $0.67 on Monday, reaching $131.70. The company’s stock had a trading volume of 1,088,600 shares, compared to its average volume of 1,222,412. The company has a market cap of $17,042.51, a price-to-earnings ratio of 21.73, a price-to-earnings-growth ratio of 2.47 and a beta of 0.31. The company has a debt-to-equity ratio of 2.35, a current ratio of 1.22 and a quick ratio of 0.86. Clorox Co has a 52-week low of $124.09 and a 52-week high of $150.40.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Friday, February 2nd. The company reported $1.23 EPS for the quarter, beating the Zacks’ consensus estimate of $1.22 by $0.01. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.43 billion. Clorox had a return on equity of 126.70% and a net margin of 13.21%. The business’s quarterly revenue was up .7% compared to the same quarter last year. During the same period last year, the company earned $1.14 EPS. equities analysts forecast that Clorox Co will post 6.23 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 11th. Shareholders of record on Wednesday, April 25th will be given a $0.96 dividend. This represents a $3.84 dividend on an annualized basis and a yield of 2.92%. This is a positive change from Clorox’s previous quarterly dividend of $0.84. The ex-dividend date of this dividend is Tuesday, April 24th. Clorox’s dividend payout ratio (DPR) is presently 55.45%.

Several equities analysts have commented on CLX shares. Deutsche Bank started coverage on Clorox in a report on Wednesday, December 13th. They issued a “hold” rating and a $142.00 price target for the company. Wells Fargo & Co reaffirmed a “hold” rating and issued a $130.00 price target on shares of Clorox in a report on Wednesday, December 13th. Consumer Edge raised Clorox from a “neutral” rating to an “outperform” rating in a report on Friday, November 10th. Morgan Stanley cut their price target on Clorox from $138.00 to $128.00 and set an “equal weight” rating for the company in a report on Thursday, November 2nd. Finally, Zacks Investment Research cut Clorox from a “buy” rating to a “hold” rating in a report on Monday, January 22nd. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $132.46.

In other Clorox news, SVP Michael R. Costello sold 10,574 shares of the stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total value of $1,438,169.74. Following the transaction, the senior vice president now directly owns 34,867 shares in the company, valued at approximately $4,742,260.67. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.00% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION WARNING: “Trilogy Capital Inc. Acquires Shares of 3,800 Clorox Co (CLX)” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/19/trilogy-capital-inc-purchases-new-position-in-clorox-co-clx.html.

Clorox Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply